Journal of Vascular Surgery
Volume 46, Issue 1 , Pages 62-70 , July 2007

Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease

Results of this study were presented at Sixteenth European Chapter Congress of the International Union of Angiology, EUROCHAP 2005, Glasgow, United Kingdom, Oct 25-27, 2005.

  • Mallik R. Thatipelli, MBBS

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn
    • ,
  • Patricia A. Pellikka, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn
    • ,
  • Robert D. McBane, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn
    • ,
  • Thom W. Rooke, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn
    • ,
  • Gabriela A. Rosales, BS

      Affiliations

    • Division of Biostatistics, Mayo Clinic, Rochester, Minn.
    • ,
  • David Hodge, BS

      Affiliations

    • Division of Biostatistics, Mayo Clinic, Rochester, Minn.
    • ,
  • Regina M. Herges, BS

      Affiliations

    • Division of Biostatistics, Mayo Clinic, Rochester, Minn.
    • ,
  • Waldemar E. Wysokinski, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn
    • Corresponding Author InformationReprint requests: Waldemar E. Wysokinski, MD, Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, 200 First St SW, Rochester, MN 55905.

Received 25 October 2006 ,Accepted 11 March 2007.

References 

  1. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746–2753
  2. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510–515
  3. Stoffers HE, Rinkens PE, Kester AD, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol. 1996;25:282–290
  4. Hertzer NR, Beven EG, Young JR, O’Hara PJ, Ruschhaupt WF, Graor RA, et al. Coronary artery disease in peripheral vascular patients (A classification of 1000 coronary angiograms and results of surgical management). Ann Surg. 1984;199:223–233
  5. Mukherjee D, Eagle KA, Smith DE. Impact of extracardiac vascular disease on acute prognosis in patients who undergo percutaneous coronary interventions. Am J Cardiol. 2003;92:972–974
  6. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–386
  7. Caruana MF, Bradbury AW, Adam DJ. The validity, reliability, reproducibility and extended utility of ankle to brachial pressure index in current vascular surgical practice. Eur J Vasc Endovasc Surg. 2005;29:443–451
  8. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119–128
  9. Vogt MT, McKenna M, Wolfson SK, Kuller LH. The relationship between ankle brachial index, other atherosclerotic disease, diabetes, smoking and mortality in older men and women. Atherosclerosis. 1993;101:191–202
  10. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19:538–545
  11. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes (A systematic review). Arterioscler Thromb Vasc Biol. 2005;25:1463–1469
  12. Geleijnse ML, Fioretti PM, Roelandt JRTC. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol. 1997;30:595–606
  13. Anthopoulos LP, Bonou MS, Kardaras FG, Sioras EP, Kardara DN, Sideris AM, et al. Stress echocardiography in elderly patients with coronary artery disease. J Am Coll Cardiol. 1996;28:52–59
  14. Marwick T, Willemart B, D’Hondt AM, Baudhuin T, Wijns W, Detry JM, et al. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion (Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography). Circulation. 1993;87:345–354
  15. Sawada SG, Seger DS, Ryan T, Brown SE, Dohan AM, Williams R, et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation. 1991;83:1605–1614
  16. Poldermans D, Fioretti PM, Forster T, Thomson IR, Boersma E, el-Said EM, et al. Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation. 1993;87:1506–1512
  17. Lane RT, Sawada SG, Segar DS, Ryan T, Lalka SG, Williams R, et al. Dobutamine stress echocardiography for assessment of cardiac risk before noncardiac surgery. Am J Cardiol. 1991;68:976–977
  18. Chuah SC, Pellikka PA, Roger VL, McCully RB, Seward JB. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation. 1998;97:1474–1480
  19. Chaowalit N, Maalouf JF, Rooke TW, Barnes ME, Bailey KR, Pellikka PA. Prognostic significance of chronotropic response to dobutamine stress echocardiography in patients with peripheral arterial disease. Am J Cardiol. 2004;94:1523–1528
  20. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–3167
  21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  22. Therneau T, Sicks J, Bergstralh E, Offord J. Expected survival based on hazard rates. Section of biostatistics. Rochester, Minn: Mayo Clinic; 1994;Technical report series. No. 52. March
  23. Wysokinski WE, Spittell PC, Pellikka PA, Miller WL, Seward JB. Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease (New noninvasive test for evaluation of peripheral circulation?). Intern Angiology. 1998;17:201–207
  24. Pellikka PA, Roger VL, Oh JK, Miller FA, Seward JB, Tajik AJ. Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc. 1995;70:16–27
  25. Quinones M, Wagoner A, Reduto L, Nelson JG, Young JB, Winters WL, et al. A new, simplified and accurate method for determining ejection fraction with 2-dimentional echocardiography. Circulation. 1981;64:744–753
  26. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358–367
  27. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J. 1984;108:150–158
  28. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517–538
  29. Cotter G, Cannon CP, McCabe CH. OPUS-TIMI 16 Investigators. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J. 2003;145:622–627
  30. Sutton-Tyrrell K, Rihal C, Sellers MA, Burek K, Trudel J, Roubin G, et al. Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol. 1998;81:375–381
  31. Rihal CS, Sutton-Tyrrell K, Guo P, Keller NM, Jandova R, Sellers MA, et al. Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation. Circulation. 1999;100:171–177
  32. Eagle KA, Rihal CS, Foster ED the Coronary Artery Surgery Study (CASS) Investigators. Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. J Am Coll Cardiol. 1994;23:1091–1095
  33. Papamichael CM, Lekakis JP, Stamatelopoulos KS, Papaioannou TG, Alevizaki MK, Cimponeriu AT, et al. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol. 2000;86:615–618
  34. van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction (The Rotterdam Study). Circulation. 2004;109:1089–1094
  35. Boneu B, Leger P, Arnaud C. Haemostatic system activation and prediction of vascular events in patients presenting with stable peripheral arterial disease of moderate severity. Blood Coagul Fibrinolysis. 1998;9:129–135
  36. Shankar VK, Chaudhury S, Ray S, Uthappa MC, Handa A, Hands LJ. Changes in blood coagulability as it traverses the ischemic limb. J Vasc Surg. 2004;39:1033–1042
  37. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329–1339
  38. Mukherjee D, Topol EJ, Moliterno DJ, Brennan DM, Ziada K, Cho L CREDO Investigators. Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment. Heart. 2006;92:49–51
  39. CHARISMA Investigators. Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events. N Engl J Med. 2006;354:1706–1717
  40. Undas A, Brummel-Ziedins KE, Mann KG. Statins and blood coagulation. Arterioscler Thromb Vasc Biol. 2005;25:287–294

 Competition of interest: none.Statistical support was provided by discretionary funding from the Cardiovascular Division at Mayo Clinic.CME article

PII: S0741-5214(07)00461-2

doi: 10.1016/j.jvs.2007.03.022

Journal of Vascular Surgery
Volume 46, Issue 1 , Pages 62-70 , July 2007

Article Tools

* Image Usage & Resolution